Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Researchers analyzed global trends in multidrug-resistant tuberculosis (MDR-TB) among children and adolescents, revealing ...

Previous studies have reported the prevalence of silicosis among agate-stone workers to range from 18% to 69%, with the rate ...

The rise in multidrug-resistant tuberculosis MDR-TB among children is raising global health concerns Learn about its causes alarming trends and the urgent need for action ...

Dr Shreya Dubey - Consultant - Neonatology & Paediatrics, CK Birla Hospital Gurgaon revealed that children are highly ...

The Trump administration's freeze on foreign aid delivered through the US Agency for International Development (USAID), and ...

Researchers reviewed previously published studies to understand trends in multidrug-resistant treatment of TB in children and ...

A recent study published in paediatric Research has shed light on the rising incidence of multidrug-resistant tuberculosis ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

In an interview with The American Journal of Managed Care, Michael A. Bernstein, MD, stressed the need for effective ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...